JPS6081127A - 食欲抑制剤 - Google Patents

食欲抑制剤

Info

Publication number
JPS6081127A
JPS6081127A JP58192015A JP19201583A JPS6081127A JP S6081127 A JPS6081127 A JP S6081127A JP 58192015 A JP58192015 A JP 58192015A JP 19201583 A JP19201583 A JP 19201583A JP S6081127 A JPS6081127 A JP S6081127A
Authority
JP
Japan
Prior art keywords
appetite
deoxy
glucose
group
oral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58192015A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0354644B2 (enExample
Inventor
Yoshikazu Hinohara
日野原　好和
Rokuro Umibe
海部　禄郎
Isao Matsunaga
功 松永
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP58192015A priority Critical patent/JPS6081127A/ja
Priority to US06/660,421 priority patent/US4696919A/en
Priority to DE8484112314T priority patent/DE3474109D1/de
Priority to EP84112314A priority patent/EP0137514B1/en
Publication of JPS6081127A publication Critical patent/JPS6081127A/ja
Publication of JPH0354644B2 publication Critical patent/JPH0354644B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
JP58192015A 1983-10-13 1983-10-13 食欲抑制剤 Granted JPS6081127A (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP58192015A JPS6081127A (ja) 1983-10-13 1983-10-13 食欲抑制剤
US06/660,421 US4696919A (en) 1983-10-13 1984-10-10 Method of preventing and treating obesity
DE8484112314T DE3474109D1 (en) 1983-10-13 1984-10-12 Compounds and compositions for use in preventing and treating obesity
EP84112314A EP0137514B1 (en) 1983-10-13 1984-10-12 Compounds and compositions for use in preventing and treating obesity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58192015A JPS6081127A (ja) 1983-10-13 1983-10-13 食欲抑制剤

Publications (2)

Publication Number Publication Date
JPS6081127A true JPS6081127A (ja) 1985-05-09
JPH0354644B2 JPH0354644B2 (enExample) 1991-08-20

Family

ID=16284181

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58192015A Granted JPS6081127A (ja) 1983-10-13 1983-10-13 食欲抑制剤

Country Status (4)

Country Link
US (1) US4696919A (enExample)
EP (1) EP0137514B1 (enExample)
JP (1) JPS6081127A (enExample)
DE (1) DE3474109D1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937077A (en) * 1987-09-21 1990-06-26 Eastman Kodak Company Method for improving feed conversion of meat-producing animals by oral administration of 2-deoxy-D-hexose
US5496553A (en) * 1988-04-12 1996-03-05 Battelle Development Corporation Methods and compositions for the treatment of niddm
CN1183913C (zh) * 2001-02-28 2005-01-12 中国人民解放军第三军医大学 N－乙酰－d－氨基葡萄糖在制备心脑抗缺血、缺氧药物中的应用
EP3801496A4 (en) 2018-06-05 2022-07-06 Flagship Pioneering Innovations V, Inc. SUBSTANCES AND METHODS OF USE FOR THE TREATMENT OF METABOLIC DISEASES AND NON-ALCOHOL FATTY LIVER
CN113413390B (zh) * 2021-06-24 2022-08-30 河南大学 4-脱氧-n-乙酰氨基葡萄糖作为革兰氏阳性菌抗菌添加剂的应用
WO2023086877A1 (en) * 2021-11-12 2023-05-19 Ayuvis Research, Inc. Novel compositions and therapeutic methods

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2907697A (en) * 1958-05-20 1959-10-06 Pfizer & Co C Therapeutic compositions

Also Published As

Publication number Publication date
DE3474109D1 (en) 1988-10-27
US4696919A (en) 1987-09-29
JPH0354644B2 (enExample) 1991-08-20
EP0137514A3 (en) 1985-06-12
EP0137514B1 (en) 1988-09-21
EP0137514A2 (en) 1985-04-17

Similar Documents

Publication Publication Date Title
RU2201272C2 (ru) Применение ингибиторов желудочно-кишечной липазы
JP2001503737A (ja) 糖尿病の発生を防止するためのシブトラミン類似体の利用
JP2005527599A (ja) 肥満および摂食障害におけるゾニサミドの使用
JPH11506766A (ja) 炎症反応を抑制するためのジ−ベータ−ｄ−グルコピラノシルアミン化合物の使用、及び合成方法
Green et al. comparison of two doses of balsalazide in maintaining ulcerative colitis in remission over 12 months
JP2001513506A (ja) タイプｉｉ糖尿病のクロム／ビオチン治療
JPH0733332B2 (ja) 痴呆症状改善・治療剤
US3867539A (en) Method of producing anorexia as a treatment for obesity
KR950002884B1 (ko) 아세트알데히드의 독성을 감소시키는 조성물
CN109689057A (zh) 用于治疗代谢失调的组合物和方法
JPH0232015A (ja) 薬剤の製造のためのモノ置換セレン有機化合物の使用、ならびにそれから製造される薬剤およびその薬剤の製造方法
JPH0354644B2 (enExample)
JP3982889B2 (ja) イブプロフェン含有医薬製剤
US3961073A (en) Antidepressant
SK287832B6 (sk) Use of acetyl L-carnitine in association with biotin for the treatment of patients with Type 2 insulin-resistant diabetes mellitus.
JPH01131113A (ja) 脳障害治療剤
EP4079306B1 (en) Btk inhibitor for use in the treatment of iga nephropathy or purpura nephritis
JP2711939B2 (ja) ６−クロロ−５−フルオロ−３−（２−テノイル）−２−オキシンドール−１−カルボキサミドのリジン塩
EP0818198A1 (en) Potentiation of drug response by increasing serotonin availability
JP2503985B2 (ja) 催眠鎮静剤
TWI672145B (zh) 預防及／或治療代謝疾病的醫藥組合物及其用途
US3646213A (en) Compositions and methods for treating depression with combinations of l-3 4-dihydroxyphenylalanine and a hydrazine
TW200539859A (en) Methods for increasing neurotransmitter levels using hydroxycitric acid
Campbell Absorption, distribution and metabolism of fenfluramine
FR2555899A1 (fr) Composition pharmaceutique contenant au moins un derive d'acide glycyrrhetinique et au moins un derive de xanthine